Could Mednax Holding Company (NYSE:MD) Skyrocket? The Stock Had Too Little Sellers

February 15, 2018 - By Michael Collier

 Could Mednax Holding Company (NYSE:MD) Skyrocket? The Stock Had Too Little Sellers

The stock of Mednax Holding Company (NYSE:MD) registered a decrease of 10.08% in short interest. MD’s total short interest was 5.63 million shares in February as published by FINRA. Its down 10.08% from 6.26M shares, reported previously. With 2.45 million shares average volume, it will take short sellers 2 days to cover their MD’s short positions. The short interest to Mednax Holding Company’s float is 6.2%.

The stock increased 2.94% or $1.61 during the last trading session, reaching $56.37. About 582,220 shares traded. MEDNAX, Inc. (NYSE:MD) has declined 18.20% since February 15, 2017 and is downtrending. It has underperformed by 34.90% the S&P500.

MEDNAX, Inc., together with its subsidiaries, provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the United States and Puerto Rico. The company has market cap of $5.23 billion. The firm offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care; and acute and chronic pain management services. It has a 19.98 P/E ratio. It also provides maternal-fetal care, including inpatient and office clinical care to expectant mothers and their unborn babies through maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians consisting of maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors.

MEDNAX, Inc. (NYSE:MD) Ratings Coverage

Among 18 analysts covering MEDNAX (NYSE:MD), 5 have Buy rating, 1 Sell and 12 Hold. Therefore 28% are positive. MEDNAX had 50 analyst reports since July 31, 2015 according to SRatingsIntel. As per Thursday, February 8, the company rating was maintained by SunTrust. The firm has “Neutral” rating by Mizuho given on Wednesday, November 9. The stock of MEDNAX, Inc. (NYSE:MD) earned “Buy” rating by Jefferies on Friday, August 26. The stock of MEDNAX, Inc. (NYSE:MD) earned “Neutral” rating by Goldman Sachs on Friday, December 9. The stock has “Underperform” rating by Bank of America on Friday, May 5. The company was maintained on Tuesday, April 11 by Jefferies. As per Wednesday, November 1, the company rating was maintained by KeyBanc Capital Markets. The rating was initiated by JP Morgan with “Overweight” on Wednesday, September 16. On Friday, July 31 the stock rating was maintained by Dougherty & Company with “Buy”. The rating was maintained by Jefferies with “Hold” on Monday, June 5.

More news for MEDNAX, Inc. (NYSE:MD) were recently published by: Gurufocus.com, which released: “BTIM Corp. Buys Eversource Energy, Mednax Inc, Honeywell International Inc …” on January 29, 2018. Streetinsider.com‘s article titled: “MEDNAX, INC.” and published on February 08, 2018 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.